Glenmark gets USFDA nod for generic ophthalmic solution
Glenmark Pharma news: Glenmark Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic brimonidine tartrate and timolol maleate ophthalmic solution indicated in the treatment increased pressure in the eye caused by glaucoma or other conditions.
Glenmark Pharmaceuticals said it has received final approval from the US health regulator for its generic brimonidine tartrate and timolol maleate ophthalmic solution. Image: Official website